Amatuximab for High Mesothelin Cancers

NCT01413451 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

7

Enrollment

NIH

Sponsor class

Conditions

Carcinoma, Pancreatic Ductal
Mesothelioma
Ovarian Neoplasms
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Amatuximab (MORab-009)

Sponsor

National Cancer Institute (NCI)